Abstract:Abstract Background Mycosis fungoides (MF) is a primary cutaneous T-cell lymphoma (CTCL) that transforms from mature, skin-homing T cells and progresses during the early stages in the skin. The role of the skin microenvironment in MF development is unclear, but recent findings in a variety of cancers have highlighted the role of stromal fibroblasts in promoting or inhibiting tumorigenesis. Stromal fibroblasts are an important part of the cutaneous tumor microenvironment (TME) in MF. Here we describe studies into the interaction of TME-fibroblasts and malignant T cells to gain insight into their role in CTCL. Methods Skin from normal ( n = 3) and MF patients ( n = 3) were analyzed for FAPα by immunohistochemistry. MyLa is a CTCL cell line that retains expression of biomarkers TWIST1 and TOX that are frequently detected in CTCL patients. MyLa cells were cultured in the presence or absence of normal or MF skin derived fibroblasts for 5 days, trypsinized to detached MyL a cells, and gene expression analyzed by RT-PCR for MF biomarkers ( TWIST1 and TOX ), Th1 markers ( IFNG , TBX21 ), Th2 markers ( GATA3 , IL16 ), and proliferation marker ( MKI67 ). Purified fibroblasts were assayed for VIM and ACTA2 gene expression. Cellular senescence assay was performed to assess senescence. Results MF skin fibroblast showed increased expression of FAP-α with increasing stage compared to normal. Normal fibroblasts co-cultured with MyLa cells suppressed expression of TWIST1 ( p < 0.0006) , and TOX ( p < 0.03) , GATA3 ( p < 0.02) and IL16 ( p < 0.03), and increased expression of IFNG ( p < 0.03) and TBX21 ( p < 0.03) in MyLa cells. In contrast, MyLa cells cultured with MF fibroblasts retained high expression of TWIST1 , TOX and GATA3 . MF fibroblasts co-culture with MyLa cells increased expression of IL16 ( p < 0.01) and IL4 ( p < 0.02), and suppressed IFNG and TBX21 in MyLa cells. Furthermore, expression of MKI67 in MyLa cells was suppressed by normal fibroblasts compared to MF fibroblasts. Conclusion Skin fibroblasts represent important components of the TME in MF. In co-culture model, normal and MF fibroblasts have differential influence on T-cell phenotype in modulating expression of Th1 cytokine and CTCL biomarker genes to reveal distinct roles with implications in MF progression.

Establishment of a mouse xenograft model for mycosis fungoides

Systemic involvement in mycosis fungoides

Establishment and Characterization of a Nude Mice Model of Human Diffuse Large B-cell Lymphoma

[Establishment of Patient-Derived Xenotransplantation Models for Non-Small Cell Lung Cancer in Immune Deficient Mice].

Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma

Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice

Single-cell RNA and T-cell receptor sequencing unveil mycosis fungoides heterogeneity and a possible gene signature

Establishing a Patient-Derived Xenograft Model of Human Myxoid and Round-Cell Liposarcoma.

Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides

Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer

[Establishment of xenotransplated mouse model using primary multiple myeloma cells].

"Next top" mouse models advancing CTCL research

Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma

Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice

[Establishment of Xenografted Model of Oral Verrucous Carcinoma with Focal Squamous Cell Carcinoma Metastasizing to the Cervical Lymph Nodes in Nude Mice].

Establishment of a Mouse Model of Skin-Dominant Chronic Graft-Versus-host Disease

A novel murine syngeneic CD8 peripheral T-cell lymphoma model with preclinical applications

Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma

Establishment of Subcutaneous Xenograft Models of Human Multiple Myeloma in NOD/SCID Mice

XactMice: Humanizing Mouse Bone Marrow Enables Microenvironment Reconstitution in a Patient-Derived Xenograft Model of Head and Neck Cancer.

A syngeneic MC38 orthotopic mouse model of colorectal cancer metastasis